In the phase 3 COBRA trial, researchers sought to compare the efficacy of KRd to VRd in newly diagnosed multiple myeloma patients regardless of cytogenic risk or transplant eligibility.

ABSTRACT: Dermatoglyphics patterns otherwise known as toe or fingerprints are defined as the scientific study of fingerprints or toe prints. This started in 1892 when one of the most original ...

Abstract: The practical consensus tracking problem is studied for a class of asynchronously switched multiagent systems (MASs). The asynchronous switchings are present in the followers, the leader, ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

MADISON, Wis. — Madison-based Exact Sciences, which leads the market with in-home cancer tests Cologuard and Oncotype DX, has been acquired by Abbott for around $21 billion. In the closing of the ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy.

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Abbott said Thursday it would buy Exact Sciences, the maker of tests ...

Nov 19 (Reuters) - Medical device maker Abbott Laboratories (ABT.N), opens new tab is nearing a potential takeover of cancer test maker Exact Sciences Corp (EXAS.O), opens new tab, Bloomberg News ...